antidiabetics (ImmuLogic)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantidiabetics (ImmuLogic)
Drug Alias Nameantidiabetics (Merck)antidiabetics (ImmuLogic/Merck)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmulogic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmulogicMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A